By:
On:
In: Old Stock Analysis, Poor company, Stock analysis
Tagged:
With: 0 Comments
Company name Comdisco Holdings Company, Inc.
Stock ticker CDCO
Live stock price [stckqut]CDCO[/stckqut]
Confident Investor Rating Poor

“Comdisco Holding Company, Inc. (Comdisco Holding) was formed for the purpose
of selling, collecting or otherwise reducing to money in an orderly manner
the remaining assets of the Company and all of its direct and indirect
subsidiaries, including Comdisco, Inc. The Company’s business purpose is
limited to the orderly sale or run-off of all its remaining assets. Comdisco
Holding Company, Inc., as the successor company to Comdisco, Inc., emerged
from bankruptcy effective August 12, 2002. Pursuant to the Company?s first
amended joint plan of reorganization, Comdisco, Inc. emerged as a wholly
owned subsidiary of Comdisco Holding. Since emerging from bankruptcy
proceedings, the Company has focused on the monetization of its remaining
assets. Prior to the bankruptcy, Comdisco, Inc. provided technology services
worldwide to help its customers maximize technology functionality,
predictability and availability.”

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock. It is not possible to confidently invest in a company that is not currently profitable.

By:
On:
In: Commentary
With: 0 Comments

This is a series of articles describing how to quickly understand the key aspects of the annual report from a company that you have invested in with your hard earned money. This series started with an overview post on November 30, 2010.

The slow read

Now it is time to sit back and read the annual report slowly over the next few weeks. You know that you have already hit on the high points that are going to cause real concern. After you have looked at the previously described 7 items a few times, that entire exercise should take you no more than 20 minutes. Now you can spend time trying to truly understand the company and its revenue model.

It is important that this is a slow read. You don’t want to invest in a company that you don’t understand. When you read the report now, use a highlighter to mark important items. Take notes in the margins. You want to be a truly informed investor and be able to think about how the various actions by the market, global politics, and general business news will affect this company that you own. You should trust your managers to run the company effectively but you now have the opportunity to understand how and why they should be reacting to market conditions.

You don’t need to go into this depth for every report that the company puts out. Rather, once a year plan to spend several hours digging into the company via the annual report. This is your opportunity to really understand this company. It is your money, you need to be confident in your investment in this company.

Here are the links to all 9 posts of the series:

  1. The 7 critical items to read first in an annual report in 20 minutes (Part 1 of 9)
  2. The 7 critical items to read first in an annual report in 20 minutes (Part 2 of 9)
  3. The 7 critical items to read first in an annual report in 20 minutes (Part 3 of 9)
  4. The 7 critical items to read first in an annual report in 20 minutes (Part 4 of 9)
  5. The 7 critical items to read first in an annual report in 20 minutes (Part 5 of 9)
  6. The 7 critical items to read first in an annual report in 20 minutes (Part 6 of 9)
  7. The 7 critical items to read first in an annual report in 20 minutes (Part 7 of 9)
  8. The 7 critical items to read first in an annual report in 20 minutes (Part 8 of 9)
  9. The 7 critical items to read first in an annual report in 20 minutes (Part 9 of 9)

By:
On:
In: Good company, Old Stock Analysis, Stock analysis
Tagged:
With: 0 Comments
Company name Alexion Pharmaceuticals, Inc.
Stock ticker ALXN
Live stock price [stckqut]ALXN[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $125.89
Target stock price (averages with growth) $204.31
Target stock price (averages with no growth) $126.37
Target stock price (manual assumptions) $114.35

“Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company,
which is engaged in the discovery, development and commercialization of
biologic therapeutic products aimed at treating patients with severe and
life-threatening disease states, including hematologic, kidney and
neurologic diseases, transplant rejection, cancer and autoimmune disorders.
Its marketed product Soliris (eculizumab) is a therapy approved for the
treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). In
April 2009 and August 2009, the United States food and drug administration
(FDA) and the European Commission (E.C.), respectively, granted Soliris
orphan drug designation for the treatment of patients with atypical
Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island
manufacturing facility received regulatory approval from the E.C. for the
production of Soliris. ”

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

By:
On:
In: Old Stock Analysis, Poor company, Stock analysis
Tagged:
With: 0 Comments
Company name Tier Technologies, Inc.
Stock ticker TIER
Live stock price [stckqut]TIER[/stckqut]
Confident Investor Rating Poor

“Tier Technologies, Inc. (Tier) is a provider of biller direct electronic
payment solutions, through its primary brand Official Payments. These
solutions provide payment services via multiple channels, including the
Internet, automated Interactive Voice Response (IVR), call center and
point-of-sale (POS), environments. Its solutions include multiple enhanced
payment services, including convenience fee payments, absorbed payments,
payment reminder and automated payment scheduling. It also offers its
clients a range of payment choices, including credit and debit cards,
electronic checks, cash and money orders, and emerging payment methods to
meet the needs of their customers. Its segments include Electronic Payment
Solutions (EPS) and Wind-down operations. ”

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock. It is not possible to confidently invest in a company that is not currently profitable.